TR199900764T2 - Bir östrojen bilesigi ve progestasyonel bir bilesikten olusan hormonal bir terkip. - Google Patents

Bir östrojen bilesigi ve progestasyonel bir bilesikten olusan hormonal bir terkip.

Info

Publication number
TR199900764T2
TR199900764T2 TR1999/00764T TR9900764T TR199900764T2 TR 199900764 T2 TR199900764 T2 TR 199900764T2 TR 1999/00764 T TR1999/00764 T TR 1999/00764T TR 9900764 T TR9900764 T TR 9900764T TR 199900764 T2 TR199900764 T2 TR 199900764T2
Authority
TR
Turkey
Prior art keywords
compound
estroprogestative
composition consisting
progestational
estrogen
Prior art date
Application number
TR1999/00764T
Other languages
English (en)
Inventor
Lanquetin Michel
Paris Jacques
- Louis Thomas Jean
Original Assignee
Laboratoire Theramex S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199900764(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Theramex S.A. filed Critical Laboratoire Theramex S.A.
Publication of TR199900764T2 publication Critical patent/TR199900764T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Bu bulus terapötik kimya alani ve özellikle de hormonal farmasötik teknikleri ile ilgilidir. Daha ayrintili olarak, dogal veya suni menopozlardaki östrojenik bozukluklari düzeltmek veya yumurtaliklarinin aktif oldugu dönemlerinde kadinlardaki ovülasyonu durdurmak amaciyla estroprogestatif bir birlesimden olusmus yeni farmasötik terkiplerdir. Ayrica bulus, östrojenik maddenin ve progestatif maddenin birlikte uygulandigi ve araliksiz veya ara verilerek uygulanabilen bir östroprogestatif karisimla ilgilidir. Bu bulusun bir baska konusu da, bu yeni östroprogestatif farmasötik terkipler için bir preparasyon prosesidir.
TR1999/00764T 1996-10-08 1997-10-08 Bir östrojen bilesigi ve progestasyonel bir bilesikten olusan hormonal bir terkip. TR199900764T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (fr) 1996-10-08 1996-10-08 Nouvelle composition hormononale et son utilisation

Publications (1)

Publication Number Publication Date
TR199900764T2 true TR199900764T2 (tr) 1999-07-21

Family

ID=9496456

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00764T TR199900764T2 (tr) 1996-10-08 1997-10-08 Bir östrojen bilesigi ve progestasyonel bir bilesikten olusan hormonal bir terkip.

Country Status (38)

Country Link
US (4) US6831073B1 (tr)
EP (2) EP1334725B1 (tr)
JP (1) JP4883542B2 (tr)
KR (2) KR100782638B1 (tr)
CN (3) CN1239893A (tr)
AP (1) AP1171A (tr)
AR (2) AR009113A1 (tr)
AT (2) ATE353652T1 (tr)
AU (1) AU745571B2 (tr)
BR (1) BR9712274A (tr)
CA (1) CA2268358C (tr)
CL (1) CL2011000017A1 (tr)
CZ (1) CZ298402B6 (tr)
DE (3) DE69721314T2 (tr)
DK (2) DK0956022T3 (tr)
DZ (1) DZ2327A1 (tr)
ES (2) ES2198006T3 (tr)
FR (2) FR2754179B1 (tr)
HK (1) HK1210708A1 (tr)
HU (2) HU227450B1 (tr)
ID (1) ID21569A (tr)
IL (1) IL129194A (tr)
LU (1) LU91932I2 (tr)
MA (1) MA24370A1 (tr)
MY (1) MY128482A (tr)
NO (3) NO324357B1 (tr)
NZ (1) NZ334876A (tr)
OA (1) OA11033A (tr)
PL (1) PL192979B1 (tr)
PT (2) PT1334725E (tr)
RU (1) RU2274450C2 (tr)
SK (2) SK285455B6 (tr)
TN (1) TNSN97164A1 (tr)
TR (1) TR199900764T2 (tr)
TW (1) TW491704B (tr)
WO (1) WO1998015279A1 (tr)
YU (1) YU18099A (tr)
ZA (1) ZA979011B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
GT200500315A (es) * 2004-11-02 2006-06-06 Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
US20080242650A1 (en) * 2007-03-26 2008-10-02 Jean-Louis Thomas Oral contraceptive regimen
RU2332219C1 (ru) * 2007-03-30 2008-08-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Средство для модуляции плотности н2-гистаминовых рецепторов сердца при менопаузе
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
AU2021271338A1 (en) * 2020-10-16 2023-06-22 Theramex HQ UK Limited Methods of contraception using nomegestrol acetate and estradiol
KR102744791B1 (ko) 2022-07-05 2024-12-19 주식회사 이음정보 소멸특허 관리 및 특허거래 시스템

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
HU214598B (hu) 1987-09-24 1998-04-28 Jencap Research Ltd Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
AU2926997A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041872A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
AU2926897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041869A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
AU2815897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
AU4043597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
AU3961697A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
ES2229378T3 (es) 1996-07-26 2005-04-16 Wyeth Anticonceptivo oral.
AU3888597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP1007052B1 (en) 1997-08-27 2004-10-13 Ortho-McNeil Pharmaceutical, Inc. Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CN1270521A (zh) 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Also Published As

Publication number Publication date
AU4627397A (en) 1998-05-05
JP2002509524A (ja) 2002-03-26
HUS1200002I1 (hu) 2016-08-29
CN101229173A (zh) 2008-07-30
MY128482A (en) 2007-02-28
ID21569A (id) 1999-06-24
HK1210708A1 (en) 2016-05-06
DE122012000010I1 (de) 2012-04-19
NO991593D0 (no) 1999-03-31
CA2268358C (fr) 2010-04-20
EP1334725A3 (fr) 2004-01-21
FR12C0005I1 (fr) 2012-02-24
EP1334725A2 (fr) 2003-08-13
LU91932I9 (tr) 2018-12-27
PT956022E (pt) 2003-07-31
PL192979B1 (pl) 2006-12-29
CZ9901120A3 (cs) 2000-11-15
MA24370A1 (fr) 1998-07-01
US6831073B1 (en) 2004-12-14
NO2012002I2 (no) 2013-04-02
SK43899A3 (en) 1999-12-10
DE69721314D1 (de) 2003-05-28
CA2268358A1 (fr) 1998-04-16
OA11033A (fr) 2003-03-06
ZA979011B (en) 1998-06-03
EP1334725B1 (fr) 2007-02-14
SK285455B6 (sk) 2007-01-04
LU91932I2 (fr) 2012-03-13
US20040220163A1 (en) 2004-11-04
HU227450B1 (en) 2011-06-28
NZ334876A (en) 2001-06-29
CL2011000017A1 (es) 2011-06-24
AU745571B2 (en) 2002-03-21
AP9901500A0 (en) 1999-06-30
AR073972A2 (es) 2010-12-15
US20070281912A1 (en) 2007-12-06
PL332610A1 (en) 1999-09-27
TNSN97164A1 (fr) 1999-12-31
DE69737373T2 (de) 2007-06-21
FR2754179B1 (fr) 1998-12-24
BR9712274A (pt) 1999-08-31
HUP9904508A3 (en) 2001-01-29
KR20000048981A (ko) 2000-07-25
AR009113A1 (es) 2000-03-08
CN1239893A (zh) 1999-12-29
PT1334725E (pt) 2007-05-31
IL129194A0 (en) 2000-02-17
AP1171A (en) 2003-06-30
DE69737373D1 (de) 2007-03-29
ES2198006T3 (es) 2004-01-16
HUP9904508A2 (hu) 2000-06-28
EP0956022B1 (fr) 2003-04-23
DK0956022T3 (da) 2003-08-04
EP0956022A1 (fr) 1999-11-17
US6906049B1 (en) 2005-06-14
TW491704B (en) 2002-06-21
NO2012002I1 (no) 2012-01-24
JP4883542B2 (ja) 2012-02-22
KR100782638B1 (ko) 2007-12-06
NO2017043I2 (no) 2019-01-25
IL129194A (en) 2003-06-24
WO1998015279A1 (fr) 1998-04-16
NO324357B1 (no) 2007-10-01
US7749987B2 (en) 2010-07-06
DZ2327A1 (fr) 2002-12-28
ATE238057T1 (de) 2003-05-15
NO2017043I1 (no) 2017-08-08
KR20060084864A (ko) 2006-07-25
NO991593L (no) 1999-06-07
RU2274450C2 (ru) 2006-04-20
ATE353652T1 (de) 2007-03-15
YU18099A (sh) 2002-03-18
FR12C0005I2 (fr) 2016-06-24
DE69721314T2 (de) 2004-02-12
SK285056B6 (sk) 2006-05-04
ES2282539T3 (es) 2007-10-16
CZ298402B6 (cs) 2007-09-19
FR2754179A1 (fr) 1998-04-10
DK1334725T3 (da) 2007-06-11
CN104706641A (zh) 2015-06-17

Similar Documents

Publication Publication Date Title
Sitruk-Ware et al. The use of newer progestins for contraception
YU54602A (sh) Drospirenon za terapiju zamene hormona
US20040243606A1 (en) Hormonal contraceptive product
Schürmann et al. Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens
EA200201000A1 (ru) Гормон-заместительная терапия
KR20060126671A (ko) 에스트로겐 및 프로게스틴을 포함하는 연장 사용 조합제
DK0836506T3 (da) Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
RU95118436A (ru) Гормональная заместительная терапия
CA2205897A1 (en) Compositions and methods for contraception and for treatment of benign gynecological disorders
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
EA200301022A1 (ru) Гормональная заместительная терапия
WO2003049744B1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
CZ298402B6 (cs) Použití farmaceutického prostredku obsahujícího estrogen a nomegestrolacelát
ES2348038T3 (es) Preparado polifasico para la contracepcion sobre la base de un estrogeno natural.
DE69525181D1 (de) Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie
KR100729311B1 (ko) 호르몬 대체 요법(ｈｒｔ)용 조성물의 성분으로서의메조프로게스틴 (프로게스테론 수용체 조절물질)
Whitehead Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data
KR19990087672A (ko) 호르몬 대체 치료를 위한 순차적 에스트로겐/프로게스테론길항제 배합
RU1789216C (ru) Состав, обладающий контрацептивным действием
Sobel Progestins in preventive hormone therapy: including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Neves et al. Combined hormonal contraception (CHC)
Aksel Therapeutic approaches to androgen excess
Mahapatra et al. Ethinyl Estradiol+ Dienogest.
HISAW et al. INFLUENCE OF A POTENTIATOR OF ESTROGEN IN THE INHIBITION OF PROGESTERONE IN DEVELOPMENT OF DECIDUOMATA.